Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NCDL
NCDL logo

NCDL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nuveen Churchill Direct Lending Corp (NCDL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
14.580
1 Day change
0.90%
52 Week Range
17.270
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Nuveen Churchill Direct Lending Corp (NCDL) is not a strong buy at the moment for a beginner investor with a long-term horizon. The lack of positive financial growth, absence of recent news catalysts, and mixed analyst ratings suggest that this stock may not be the best investment opportunity right now. While technical indicators show some short-term strength, the long-term fundamentals and sentiment do not support a strong buy decision.

Technical Analysis

The MACD is positive and expanding, suggesting bullish momentum. RSI is neutral at 76.219, and moving averages are converging, indicating no clear trend. The stock is trading near its resistance level (R1: 14.379), which may limit further upside in the short term.

Positive Catalysts

  • The MACD indicates bullish momentum, and the stock has a 60% chance of gaining 2.36% in the next month.

Neutral/Negative Catalysts

  • Analyst ratings have been revised downward, and there are no significant insider or hedge fund trading trends. No recent news or congress trading data to act as a catalyst.

Financial Performance

In Q4 2025, revenue dropped by -21.34% YoY to $44.59M, net income dropped by -45.95% YoY to $15.92M, and EPS dropped by -40.74% YoY to $0.32. Gross margin also declined slightly to 96.77%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Truist and Citizens lowered their price targets to $16 but maintained Buy and Outperform ratings, respectively. Wells Fargo lowered its price target to $13 and maintains an Equal Weight rating.

Wall Street analysts forecast NCDL stock price to rise
2 Analyst Rating
Wall Street analysts forecast NCDL stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 14.450
sliders
Low
15
Averages
16.5
High
18
Current: 14.450
sliders
Low
15
Averages
16.5
High
18
UBS
Neutral
maintain
AI Analysis
2026-04-20
New
Reason
UBS
Price Target
AI Analysis
2026-04-20
New
maintain
Neutral
Reason
UBS raised the firm's price target on Nuveen Churchill to $15.50 from $14.75 and keeps a Neutral rating on the shares.
Truist
Buy
maintain
$18 -> $16
2026-03-04
Reason
Truist
Price Target
$18 -> $16
2026-03-04
maintain
Buy
Reason
Truist lowered the firm's price target on Nuveen Churchill to $16 from $18 and keeps a Buy rating on the shares as part of a broader research on BDCs - business development companies - with updates on several models post earnings. The modest decline in 2026 estimate results from lower assumed portfolio growth as the firm assumes utilization of its recently announced $50M share repurchase plan this year, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NCDL
Unlock Now

People Also Watch